BridgeBio Oncology Therapeutics, Inc. (BBOT)
2.01 USD+1.52%
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$161.3M
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -1,232.23
BridgeBio Oncology Therapeutics, Inc. (BBOT) is not among the 30 most-held stocks of the tracked superinvestor set. Price 2.01 USD; market cap $161.3M.
Price & valuation
Prev Close1.98
Open2.02
Day Range1.92 – 2.09
52 Week Range—
Volume—
Avg Volume (3M)—
BetaVolatility vs the market. Above 1: swings harder than the index.1.692 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProFrequently Asked Questions
Which superinvestors own BBOT?
BridgeBio Oncology Therapeutics, Inc. (BBOT) is not among the 30 most-held stocks of the tracked superinvestor set.
Is institutional sentiment on BBOT bullish or bearish?
BBOT is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.